ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1071

Single-Cell RNA Sequencing of Human Podocytes, Endothelial Cells, and Tubular Cells Identifies Markers and Gene Profiles Differentiating Class IV and Class V Renal Disease in Lupus Nephritis

Evan Der1, Kemal Akat2, Robert Clancy3, Beatrice Goilav4, Anna R. Broder5, H. Michael Belmont6, Peter M. Izmirly7, Nicole Jordan8, Tao Wang9, James Pullman10, Daniel Schwartz10, Ming Wu11, Thomas Tuschl2, Jill P. Buyon3 and Chaim Putterman12, 1Albert Einstein College of Medicine, Bronx, NY, 2Rockefeller University, New York, NY, 3Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 4Division of Nephrology, Children's Hospital at Montefiore, Bronx, NY, 5Rheumatology-Forchheimer 701N, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY, 6Hosp for Joint Disease, New York, NY, 7Rheumatology, NYU School of Medicine, New York, NY, 8Montefiore Medical Center, New York, NY, 9Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY, 10Pathology, Albert Einstein College of Medicine, Bronx, NY, 11Pathology, New York University School of Medicine, New York, NY, 12Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: cytokines, lupus nephritis and systemic lupus erythematosus (SLE), RNA

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis: Genetics, Gene Expression, and Epigenetics

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:
Currently, classification and treatment decisions in lupus nephritis (LN) are
largely based on renal histology. Transcriptome analysis may accurately
differentiate types of renal involvement, and better inform treatment outcome
and prognosis. Single-cell RNAseq is an emerging technology that allows for
resolution of differential gene expression at the single-cell level, thus
facilitating the detection of expression changes that would be unnoticed in
conventional bulk-tissue RNAseq. Our objectives were to determine if
single-cell RNAseq can differentiate among various cell types in LN kidney, and
distinguish between LN class IV and V.

Methods:
RNAseq was performed on ~2 mg kidney tissue from consented clinically indicated
renal biopsies in 5 SLE patients, using Fluidigm C1 Integrated Fluidic Circuits
and the C1 Single-Cell Auto Prep. cDNA libraries were prepared using the
Nextera XT DNA Library Prep Kit followed by HiSeq 2500 (Illumina) sequencing.
Sequence-read alignments were conducted using the STAR aligner, and uniquely
mapped reads were summarized at the gene level using the featureCounts
software. Differential expression analysis was performed using the DESeq2
package for R version 3.2.0.

Results:
A total of 155 single cells were characterized from LN kidney biopsies (n=36
pure class IV and n=108 pure class V). An average of 3500 genes/cell were
identified (Fig. 1a), with 50% of reads mapping to the reference genome (Fig.
1b). Through transcriptome analysis and utilization of standard lineage
markers, major renal resident and infiltrating cell types including podocytes,
endothelial cells, tubular cells, macrophages, dendritic cells, and lymphocytes
could be identified (Fig. 1c). Comparison of gene expression between cells from
class IV and class V biopsies revealed that class IV podocytes and endothelial
cells expressed significantly higher levels of complement C7 than class V cells
(p=.001 and .01, respectively). Podocytes from class IV kidney expressed significantly
higher IL-1b (p<.01) and TLR3 (p<.001) as well as IFN-γ receptor
(p<.001) and TNF receptor (p<.05). Similarly, endothelial cells from
class IV kidney demonstrated significant upregulation of several inflammatory
molecules including NF-κB (p=.005), CXCL8 (p<.05), and IL-1b
(p<.05).  Proximal tubular cells from class IV patients expressed significantly
higher levels of CXCL12 (p<.05) than those isolated from class V patients.

Conclusion:
These findings demonstrate that single-cell RNAseq is feasible and informative in
cell specific transcriptome analysis from fresh renal biopsy tissue in SLE. In this
pilot study, single-cell RNAseq correlates well with histologic classification,
and shows changes in gene expression that could directly drive or be influenced
by disease pathogenesis. If confirmed, this novel approach may identify new therapeutic
targets and track clinical responses. 


Disclosure: E. Der, None; K. Akat, None; R. Clancy, None; B. Goilav, None; A. R. Broder, None; H. M. Belmont, None; P. M. Izmirly, None; N. Jordan, None; T. Wang, None; J. Pullman, None; D. Schwartz, None; M. Wu, None; T. Tuschl, None; J. P. Buyon, None; C. Putterman, None.

To cite this abstract in AMA style:

Der E, Akat K, Clancy R, Goilav B, Broder AR, Belmont HM, Izmirly PM, Jordan N, Wang T, Pullman J, Schwartz D, Wu M, Tuschl T, Buyon JP, Putterman C. Single-Cell RNA Sequencing of Human Podocytes, Endothelial Cells, and Tubular Cells Identifies Markers and Gene Profiles Differentiating Class IV and Class V Renal Disease in Lupus Nephritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/single-cell-rna-sequencing-of-human-podocytes-endothelial-cells-and-tubular-cells-identifies-markers-and-gene-profiles-differentiating-class-iv-and-class-v-renal-disease-in-lupus-nephritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-cell-rna-sequencing-of-human-podocytes-endothelial-cells-and-tubular-cells-identifies-markers-and-gene-profiles-differentiating-class-iv-and-class-v-renal-disease-in-lupus-nephritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology